-

David Armstrong
Professor of Surgery, Co-DirectorUSC Limb Preservation ProgramDavid G. Armstrong, DPM, PhD, is an internationally recognized leader in the field of podiatric surgery, diabetic foot, limb preservation, tissue repair and wound healing. He is founder and co-director of the Southwestern Academic Limb Salvage Alliance (SALSA), a clinical and research collaborative.
As director of USC’s Center to Stream Healthcare in Place (C2SHIP), he is advancing the latest research in consumer wearables and other health technologies. In 2021, he received a USC Stevens Technology Commercialization Award for his method for treating chronic diabetic foot ulcers, just one of multiple patents he holds.
Dr. Armstrong is coeditor of the American Diabetes Association textbook, Clinical Care of the Diabetic Foot, now in its third edition. He is responsible for more than 100 books or book chapters, along with 600 peer-reviewed research papers in leading medical journals.
His achievements have garnered multiple honors, including the 2010 American Diabetes Association’s Roger E. Pecoraro Award for Lifetime Achievement in Diabetic Foot Care, the highest honor in the field.
Dr. Armstrong is founding president of the American Limb Preservation Society (ALPS), which is bringing together clinicians to help eliminate preventable amputations in the United States and worldwide. He and his Keck Medicine of USC team are working to achieve that goal for people with diabetes over the next generation.
-

Caroline Fife
CMOIntellicure -

Brenda Loft
Global Health Economic, Policy and Market Access LeaderSolventum -

Mike Griffiths
Chief Executive Officer & PresidentAOTI -

Melissa Bailey
Digital Integration Sales & Marketing Director US & AsiaMolnlycke Health Care -

Joseph Rolley
Market Access ConsultantJTR Business Consulting -

Ira Herman
Chief Science OfficerTHP -

Jennie Feight
Senior Director Health PolicyKent Imaging -

Katherine Piette
Chief Executive OfficerCorstrata -

Kris Flinn
General Manager, WoundSmartTRAK -

Jason Hanft
CEO & FounderDefender -

Kevin Richardson
CEOQualigen Therapeutics -

Patrick Cheng
CEOeKare -

Maurice Lubetzki
VP US of Business Development, Strategy, and OperationsCINESTEAM (CEMAG CARE) -

Desmond Bell
Chief Medical OfficerOMEZA -

Nick Frame
SVP Life SciencesOutcome Capital -

John Fritz
Director of Government Affairs, Reimbursement and Healthcare EconomicsMolnlycke -

Clémence Desjardin, phD
Chief Operating OfficerCINESTEAM (CEMAG CARE)
